All Stories

  1. Vitamin K plasma levels determination in human health
  2. The pitfall of treating low bone turnover: Effects on cortical porosity
  3. Turning over renal osteodystrophy dogma: direct actions of FGF23 on osteoblast β-catenin pathway
  4. Impact of Restless Leg Syndrome on mortality in patients on hemodialysis: still debatable
  5. Longevity protein klotho is induced by a single bout of exercise
  6. Parathyroidectomy Improves Restless Leg Syndrome in Patients on Hemodialysis
  7. Abnormalities of Anthropometric, Hemodynamic, and Autonomic Variables in Offspring of Hypertensive Parents
  8. Serum Sclerostin: Not Only a Matter of Measurement But Also of Meaning
  9. Dialysate and Serum Potassium in Hemodialysis
  10. Furosemide Increases the Risk of Hyperparathyroidism in Chronic Kidney Disease
  11. Factors associated with subendocardial ischemia risk in patients on hemodialysis
  12. Parathyroidectomy: better late than never
  13. Sclerostin, Osteocytes, and Chronic Kidney Disease - Mineral Bone Disorder
  14. Fractures in chronic kidney disease
  15. Peritoneal dialysis per se is a risk factor for sclerostin-associated adynamic bone disease
  16. Parathyroidectomized patients have impaired capacity of peripheral vascular constriction during hemodialysis
  17. Can we compare serum sclerostin results obtained with different assays in hemodialysis patients?
  18. Coronary Artery Calcification Seen Through Chest Radiography
  19. Serum sclerostin is an independent predictor of mortality in hemodialysis patients
  20. Is parathyroidectomy always good for the heart?
  21. Correction of metabolic acidosis in hemodialysis: consequences on serum leptin and mineral metabolism
  22. Vitamin D Deficiency Aggravates Chronic Kidney Disease Progression after Ischemic Acute Kidney Injury
  23. Mineral bone disorder in chronic kidney disease: head-to-head comparison of the 5/6 nephrectomy and adenine models
  24. bariatric oxalate load
  25. Reprocessing high-flux polysulfone dialyzers does not negatively impact solute removal in short-daily online hemodiafiltration
  26. Hemodynamic Behavior During Hemodialysis: Effects of Dialysate Concentrations of Bicarbonate and Potassium
  27. Brazilian Registry of Bone Biopsy (REBRABO): design, data elements and methodology
  28. Effects of Dietary Phosphate on Adynamic Bone Disease in Rats with Chronic Kidney Disease – Role of Sclerostin?
  29. Sevelamer and CKD-associated cardiovascular disease: going further, but far from there
  30. Parathyroidectomy Improves Survival In Patients with Severe Hyperparathyroidism: A Comparative Study
  31. Persistence of Bone and Mineral Disorders 2 Years After Successful Kidney Transplantation
  32. Vertebral bone density by quantitative computed tomography mirrors bone structure histomorphometric parameters in hemodialysis patients
  33. Clinical protocol and therapeutic guidelines for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease
  34. Ankle-Brachial Index: A Simple Way to Predict Mortality among Patients on Hemodialysis - A Prospective Study
  35. Repression of osteocyte Wnt/β-catenin signaling is an early event in the progression of renal osteodystrophy
  36. Adendo das diretrizes brasileiras de prática clínica para o distúrbio mineral e ósseo na doença renal crônica capítulo 2
  37. Phosphorus Is Associated with Coronary Artery Disease in Patients with Preserved Renal Function
  38. Situação do hiperparatireoidismo secundário autônomo no Brasil: dados do censo brasileiro de paratireoidectomia
  39. Calcificação vascular na DRC
  40. Paratireoidectomia na DRC
  41. Doença óssea adinâmica
  42. Fibroblast Growth Factor 23 in Hemodialysis Patients: Effects of Phosphate Binder, Calcitriol and Calcium Concentration in the Dialysate
  43. Vitamin D status in a sunny country: Where has the sun gone?
  44. FGF-23 as a Predictor of Renal Outcome in Diabetic Nephropathy
  45. FGF-23: estado da arte
  46. Fórum nacional de discussão das diretrizes do KDIGO para o distúrbio mineral e ósseo da doença renal crônica (DMO-DRC): uma análise crítica frente à relidade Brasileira
  47. The Bone Histology Spectrum in Experimental Renal Failure: Adverse Effects of Phosphate and Parathyroid Hormone Disturbances
  48. Effects of bone remodelling on calcium mass transfer during haemodialysis
  49. Ten-Year Experience with Sevelamer and Calcium Salts as Phosphate Binders
  50. Early Control of PTH and FGF23 in Normophosphatemic CKD Patients: A New Target in CKD-MBD Therapy?
  51. Efeito da estimulação elétrica nervosa transcutânea no tratamento da dor no ombro de pacientes com doença renal crônica: relato de casos
  52. Effect of phosphate binders on oxidative stress and inflammation markers in hemodialysis patients
  53. Osteomalacia and vitamin D deficiency in the elderly
  54. Fibrose sistêmica nefrogênica: uma complicação grave do uso do gadolínio em pacientes com insuficiência renal
  55. Serum Ferritin Level Remains a Reliable Marker of Bone Marrow Iron Stores Evaluated by Histomorphometry in Hemodialysis Patients
  56. Phosphorus overload and PTH induce aortic expression of Runx2 in experimental uraemia
  57. Association of Changes in Bone Remodeling and Coronary Calcification in Hemodialysis Patients: A Prospective Study
  58. Phosphate Binder Impact on Bone Remodeling and Coronary Calcification – Results from the BRiC Study
  59. K/DOQI-recommended intact PTH levels do not prevent low-turnover bone disease in hemodialysis patients
  60. Parathyroidectomy reduces cardiovascular events and mortality in renal hyperparathyroidism
  61. Effects of parathyroidectomy on bone remodeling markers and vitamin D status in patients with chronic kidney disease–mineral and bone disorder
  62. Vascular calcification: Contribution of parathyroid hormone in renal failure
  63. Decreased in vitro osteoblast proliferation and low turnover bone disease in nonuremic proteinuric patients
  64. Osteoporosis in hemodialysis patients revisited by bone histomorphometry: A new insight into an old problem
  65. Improvement of adynamic bone disease after renal transplantation
  66. MIBI scintigraphy, indicators of cell proliferation and histology of parathyroid glands in uraemic patients
  67. Coronary calcification in hemodialysis patients: The contribution of traditional and uremia-related risk factors
  68. Adverse effects of hyperphosphatemia on myocardial hypertrophy, renal function, and bone in rats with renal failure
  69. Percutaneous ethanol (PEIT) and calcitrol (PCIT) injection therapy are ineffective in treating severe secondary hyperparathyroidism
  70. The renal osteodystrophy pattern in Brazil and Uruguay: An overview
  71. Effects of calcitriol on parathyroid function and on bone remodelling in secondary hyperparathyroidism
  72. IL-1β, TNF-α, TGF-β, and bFGF expression in bone biopsies before and after parathyroidectomy
  73. Dynamic tests of parathyroid hormone secretion using hemodialysis and calcium infusion cannot be compared
  74. High incidence of facial leontiasis and broun tumor in a population of uremic patients with secondary hyperparathiroidisn (HP)